What is OS Therapies Incorporated?
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. The company's pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. The company is listed on the AMEX in USA, operating in the Healthcare sector, with a market capitalisation of 34.87M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.